Indian J Med Microbiol Close
 

Figure 1: Summary of the trials on combination therapies in metastatic hormone-sensitive prostate cancer. ADT: Androgen deprivation therapy, PFS: Progression-free survival, OS: Overall survival, HR: Hazard ratio, NA: Not available, *CHAARTED distributed patients into high volume and low volume in which high volume of metastases was defined by the presence of visceral metastases or four or more bone lesions with at least one beyond the vertebral bodies and pelvis

Figure 1: Summary of the trials on combination therapies in metastatic hormone-sensitive prostate cancer. ADT: Androgen deprivation therapy, PFS: Progression-free survival, OS: Overall survival, HR: Hazard ratio, NA: Not available, *CHAARTED distributed patients into high volume and low volume in which high volume of metastases was defined by the presence of visceral metastases or four or more bone lesions with at least one beyond the vertebral bodies and pelvis